Drug
Nelistotug clinical trials
Also written GSK6097608.
- studies test it
- 6
- open now
- 0
- in phase 3
- 0
- first study started
- 2019
How studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
6 studies that test it; most in 2022 (2)
| Year | Studies |
|---|---|
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 0
Often tested with
Tested in the same studies.
Belrestotug (5) · Dostarlimab (4) · Remzistotug (2) · Risvutatug rezetecan (1) · Cobolimab (1) · Docetaxel (1) · Feladilimab (1) · Ipilimumab (1)
Studies
Open first, then newest update. How each study uses nelistotug is read from its arms, and is right about nine times in ten.
Testing it · 6
- First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid TumorsActive, not recruitingPhase 1GlaxoSmithKlineNCT05277051Written as Nelistotug
- A Platform Study of Novel Immunotherapy Combinations as First-Line Treatment in Participants With PD-L1 Positive Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck- GALAXIES H&N-202Active, not recruitingPhase 2GlaxoSmithKlineNCT06062420Written as Nelistotug
- A Platform Study of Novel Immunotherapy Combinations in Participants With Previously Untreated, Advanced/Metastatic Non-Small-Cell Lung CancerActive, not recruitingPhase 2GlaxoSmithKlineNCT05565378Written as Nelistotug
- Study of the Safety and Effectiveness of GSK6097608 in Participants With Advanced Solid TumorsActive, not recruitingPhase 1GlaxoSmithKlineNCT04446351Written as GSK6097608
- Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 3CompletedPhase 2GlaxoSmithKlineNCT06926673Written as Nelistotug
- Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC)CompletedPhase 2GlaxoSmithKlineNCT03739710Written as GSK6097608
Codes
What other systems call nelistotug · ClinicalTrials.gg INT015492
- UNII (FDA) 7MCC43O1YBNELISTOTUGOne source FDA
- NCI Thesaurus C176029NelistotugOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 7MCC43O1YB | NELISTOTUG | One source FDA |
| NCI Thesaurus | C176029 | Nelistotug | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.